[go: up one dir, main page]

DK2898061T3 - Probiotiske sammensætninger til behandlingen af fedme og fedme-relaterede tilstande - Google Patents

Probiotiske sammensætninger til behandlingen af fedme og fedme-relaterede tilstande Download PDF

Info

Publication number
DK2898061T3
DK2898061T3 DK13839430.9T DK13839430T DK2898061T3 DK 2898061 T3 DK2898061 T3 DK 2898061T3 DK 13839430 T DK13839430 T DK 13839430T DK 2898061 T3 DK2898061 T3 DK 2898061T3
Authority
DK
Denmark
Prior art keywords
obesis
obese
treatment
related conditions
probiotic compositions
Prior art date
Application number
DK13839430.9T
Other languages
English (en)
Inventor
Stephen Francis Olmstead
Original Assignee
Prothera Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50274705&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2898061(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Prothera Inc filed Critical Prothera Inc
Application granted granted Critical
Publication of DK2898061T3 publication Critical patent/DK2898061T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/113—Acidophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/125—Casei
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/165—Paracasei
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/181—Salivarius
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/517—Bifidum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/519—Breve
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/529—Infantis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Enzymes And Modification Thereof (AREA)
DK13839430.9T 2012-09-20 2013-08-12 Probiotiske sammensætninger til behandlingen af fedme og fedme-relaterede tilstande DK2898061T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261703257P 2012-09-20 2012-09-20
PCT/US2013/054553 WO2014046804A1 (en) 2012-09-20 2013-08-12 Probiotic compositions and methods for the treatment of obesity and obesity-related conditions

Publications (1)

Publication Number Publication Date
DK2898061T3 true DK2898061T3 (da) 2020-02-10

Family

ID=50274705

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13839430.9T DK2898061T3 (da) 2012-09-20 2013-08-12 Probiotiske sammensætninger til behandlingen af fedme og fedme-relaterede tilstande

Country Status (12)

Country Link
US (2) US20140079676A1 (da)
EP (2) EP2898061B1 (da)
JP (1) JP6286434B2 (da)
KR (2) KR20150118084A (da)
CN (1) CN104968780A (da)
AU (3) AU2013318513A1 (da)
CA (3) CA2885537C (da)
DK (1) DK2898061T3 (da)
ES (1) ES2770401T3 (da)
PL (1) PL2898061T3 (da)
PT (1) PT2898061T (da)
WO (1) WO2014046804A1 (da)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013130773A2 (en) 2012-02-29 2013-09-06 Ethicon Endo-Surgery, Inc. Compositions of microbiota and methods related thereto
WO2015013214A2 (en) 2013-07-21 2015-01-29 Whole Biome, Inc. Methods and systems for microbiome characterization, monitoring and treatment
EP2870969A1 (fr) * 2013-11-08 2015-05-13 Biocodex Composition pharmaceutique pour la réduction de la masse adipeuse
WO2015172191A1 (en) * 2014-05-12 2015-11-19 Medlab Ip Pty Ltd Probiotic compositions and uses thereof for treatment of obesity-related disorders
EP3881680B8 (en) 2014-10-31 2025-02-26 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
JP6650728B2 (ja) * 2015-03-06 2020-02-19 株式会社ファンケル ダイエット用の製剤
CA2987863A1 (en) 2015-06-01 2016-12-08 Xeno Biosciences Inc. Methods and compositions to modulate the gut microbiota and to manage weight
CN105030844A (zh) * 2015-07-13 2015-11-11 孙战强 硒和益生菌的组合物及用途
CN105039217B (zh) * 2015-07-16 2019-05-07 山东凤凰生物有限公司 一种降血糖益生菌制剂及其制备方法
GB201514302D0 (en) * 2015-07-16 2015-09-23 Dupont Nutrition Biosci Aps Lactobacilli for treating cardiac dysfunction
GB2544481B (en) * 2015-11-16 2019-12-11 Century International Enterprises Ltd A wearable article and a method for producing a wearable article
EP3386523B1 (en) * 2015-12-11 2019-10-09 Alimentary Health Limited Bifidobacterium longum for treating obesity and associated metabolic disorders
ITUB20159330A1 (it) * 2015-12-22 2017-06-22 Roelmi Hpc S R L Composizioni probiotiche e loro uso
CN105685972A (zh) * 2016-02-02 2016-06-22 武汉万德瑞生物技术有限公司 具有减脂瘦身功能的益生菌组合物及其制备方法与应用
US10792302B2 (en) 2016-02-24 2020-10-06 Noster Inc. Composition for preventing or treating metabolism disorders comprising leuconostoc mesenteroides-producing exopolysaccharide as active ingredient
WO2017155898A1 (en) * 2016-03-07 2017-09-14 Nature's Sunshine Products, Inc. Methods and compositions to improve weight loss and cardiometabolic health beyond diet and exercise
WO2017180501A1 (en) 2016-04-11 2017-10-19 President And Fellows Of Harvard College Probiotic formulations for improving athletic performance
JP6986856B2 (ja) * 2016-05-10 2021-12-22 協同乳業株式会社 トリメチルアミンを産生し難い腸内菌叢を形成するためのプロバイオティクス組成物および方法
JP6989286B2 (ja) * 2016-05-10 2022-01-05 協同乳業株式会社 動脈硬化症を予防するためのプロバイオティクス組成物および方法
CN106036911A (zh) * 2016-06-21 2016-10-26 广州宇晟生物科技有限公司 一种调节血糖水平的益生菌膳食组合物及功能食品
IT201600105831A1 (it) * 2016-10-20 2018-04-20 Probiotical Spa Una composizione a base di un estratto di Irvingia gabonensis e ceppi di Bifidobatteri per la regolazione e riduzione del peso corporeo
KR20180049731A (ko) * 2016-11-03 2018-05-11 주식회사 쎌바이오텍 비만 및 지질 관련 대사성 질환의 예방 또는 치료용 조성물
CN110520111B (zh) 2016-11-30 2023-12-19 塞诺生物科学股份有限公司 用以管理体重和调节肠道微生物群的药物制剂和方法
WO2018112740A1 (zh) * 2016-12-20 2018-06-28 深圳华大基因研究院 一种加氏乳杆菌及其培养方法和应用
CN106619743A (zh) * 2016-12-28 2017-05-10 山东龙力生物科技股份有限公司 一种具有降血糖作用的益生菌固体饮料及其制备方法
CN107050065B (zh) * 2017-03-31 2021-03-30 杭州远大生物制药有限公司 双歧四联活菌组合物的新应用
US12156892B2 (en) 2017-04-06 2024-12-03 Korea Food Research Institute Strain having activity of reducing advanced glycation end products and use thereof
KR101883253B1 (ko) * 2017-05-26 2018-07-31 경운대학교 산학협력단 유산균 발효 사과액을 포함하는 비만 또는 그 합병증 개선용 식품 조성물 및 그 제조방법
WO2018231923A1 (en) * 2017-06-15 2018-12-20 Muhammed Majeed Anti-obesity potential of garcinol
CN109223833A (zh) * 2017-07-10 2019-01-18 上海立龙生物科技有限公司 一种预防和改善肥胖的益生菌组合物
TWI640313B (zh) * 2017-08-18 2018-11-11 長庚生物科技股份有限公司 戈氏副擬桿菌用於抑制肥胖之用途
CN111372596A (zh) 2017-08-30 2020-07-03 潘德勒姆治疗公司 用于治疗微生物组相关病症的方法和组合物
CN107468717A (zh) * 2017-09-28 2017-12-15 陈元秀 一种用于人体的降血糖制剂及其制备方法
CN111601896A (zh) * 2017-09-28 2020-08-28 联邦科学技术研究组织 含异硫氰酸酯的十字花科产物及其制备方法
KR101873239B1 (ko) * 2017-10-13 2018-07-04 주식회사 지놈앤컴퍼니 락토바실러스 파라카제이 lm1010 균주 및 이를 포함하는 비만 또는 당뇨병 예방 및 치료용 조성물
CN107723261A (zh) * 2017-10-19 2018-02-23 江苏中通生物科技有限公司 一种食品发酵剂及其制备方法
EP3703719A4 (en) * 2017-11-01 2021-08-11 Medlab IP Pty Ltd. MODULATION OF THE INTESTINAL MICROBIOTA INTO PREDIABETES AND TYPE 2 DIABETES
CN109744441A (zh) * 2017-11-02 2019-05-14 健茂生物科技股份有限公司 具抗氧化功能的仙人掌果与红龙果复合发酵饮品的制备工艺
CN108157973B (zh) * 2017-12-14 2021-04-02 上海交通大学医学院附属瑞金医院 一种有益糖脂代谢功能的益生菌组合物及其制剂和应用
CA3091152A1 (en) * 2018-02-13 2019-08-22 Proviva Pharma Inc. Probiotic formulations for the treatment and alleviation of metabolic and oxidative stress, inflammation and neurodegeneration
KR102230571B1 (ko) * 2018-03-22 2021-03-22 한국식품연구원 비형광성 최종당화산물 억제용 조성물 및 이의 용도
JP7266580B2 (ja) * 2018-03-23 2023-04-28 森永乳業株式会社 学童期以降の高血糖に起因する疾患の予防のための乳幼児用組成物
KR101980527B1 (ko) 2018-03-26 2019-05-21 주식회사 지놈앤컴퍼니 신규한 락토바실러스 퍼멘텀 lm1016 균주, 및 이를 포함하는 심혈관질환 예방 또는 치료용 조성물
US10780135B2 (en) * 2018-04-05 2020-09-22 Hooman M. MELAMED Probiotic formulation and method for weight loss treatment
CN112672749B (zh) * 2018-04-11 2024-07-23 韩国生命工学研究院 具有肥胖预防或治疗效果的新的长双歧杆菌菌株或鼠李糖乳杆菌菌株及其用途
EP3781185B1 (en) * 2018-04-18 2023-08-09 Danstar Ferment AG Method for alleviating tobacco or nicotine withdrawal symptoms
WO2019209086A1 (ko) * 2018-04-27 2019-10-31 단국대학교 천안캠퍼스 산학협력단 류코노스톡 메젠테로이드 균주 및 이의 용도
CN108813262A (zh) * 2018-07-02 2018-11-16 杭州相生相成科技有限公司 一种含dha藻油的复合益生菌固体饮料
WO2020006663A1 (zh) * 2018-07-02 2020-01-09 葡萄王生技股份有限公司 用于改善代谢症候群的新颖副干酪乳杆菌 gks6、其培养基、培养方法、用途、医药组合物及可食用组合物
MX2018008663A (es) * 2018-07-13 2018-11-09 Instituto Nac De Ciencias Medicas Y Nutricion Salvador Zubiran Uso de leuconostoc mesenteroides subsp. mesenteroides sd23 para la programacion metabolica materno fetal.
US20210290700A1 (en) * 2018-08-01 2021-09-23 N.M.B. Medical Applications Ltd Orally administered supplements and methods of reducing absorption of calories and modifying the nutritional values of consumed nutrients
TWI706782B (zh) * 2018-09-04 2020-10-11 星聚樊生物科技有限公司 新穎戈氏副擬桿菌之菌株用於預防或治療肥胖之用途
IT201800009755A1 (it) * 2018-10-24 2020-04-24 Berardino Vaira Nuovi probiotici utili per eradicare l'infezione da helicobacter pylori
EA202191106A1 (ru) 2018-10-24 2021-07-20 Новозимс А/С Пробиотическая добавка для метаболического здоровья, содержащая lactobacillus
KR102043740B1 (ko) * 2018-11-19 2019-11-12 주식회사한국야쿠르트 알코올성 지방간 개선 효능을 갖는 락토바실러스 파라카제이 hy7014 및 이를 유효성분으로 함유하는 제품
JP7316802B2 (ja) 2019-02-19 2023-07-28 雪印メグミルク株式会社 糖吸収促進用組成物
CN112007051B (zh) * 2019-05-28 2022-05-10 景岳生物科技股份有限公司 一种预防中风及改善中风严重度的组合物及其用途
CN110140773A (zh) * 2019-06-27 2019-08-20 格乐瑞(无锡)营养科技有限公司 一种益生菌固体饮料、制备方法及其应用
IT201900014388A1 (it) * 2019-08-08 2021-02-08 Univ Cattolica Del Sacro Cuore Consorzio di probiotici
TWI754189B (zh) * 2019-08-14 2022-02-01 大江生醫股份有限公司 普蒂亞花萃取物用於提升皮膚細胞的粒線體活性的用途
CN110638844A (zh) * 2019-10-22 2020-01-03 江苏恒丰强生物技术有限公司 一种预防宠物2型糖尿病的复合微生态制剂及其应用
WO2021081362A1 (en) * 2019-10-25 2021-04-29 Newgen 27, Llc Synbiotic compositions for gut microbiota
CA3163992A1 (en) 2019-12-27 2021-07-01 Biopolis, S.L. Uses of lipoteichoic acid from bifidobacteria
US20230012950A1 (en) * 2019-12-31 2023-01-19 Gi Biome Lactobacillus fermentum strain, and composition for preventing or treating metabolic diseases containing same
CN111213885A (zh) * 2020-01-20 2020-06-02 齐海心 一种具有调节血脂功效的益生菌组合物及其制备方法与应用
CN111357953B (zh) * 2020-02-28 2021-12-10 南昌大学 益生菌发酵果蔬原浆产品
US20230112367A1 (en) * 2020-03-13 2023-04-13 Fitbiomics Inc. Probiotic compositions for improving human health and athletic performance
CN111587952A (zh) * 2020-05-27 2020-08-28 佛山科学技术学院 一种降低家犬体脂沉积的益生菌添加剂
CN111979161B (zh) * 2020-09-30 2022-04-15 无锡特殊食品与营养健康研究院有限公司 一株可降低血管平滑肌细胞内活性氧水平的长双歧杆菌
EP4014755A1 (en) * 2020-12-15 2022-06-22 DuPont Nutrition Biosciences ApS Improving protein digestion and amino acid bioavailability by probiotic strains
EP4014756A1 (en) * 2020-12-15 2022-06-22 DuPont Nutrition Biosciences ApS Bioprocessing of protein with probiotic bacteria to improve amino acid and peptide availability
KR102504671B1 (ko) * 2021-01-14 2023-02-27 전남대학교산학협력단 락토바실러스 존스니 jnu3402 균주 및 이를 포함하는 식품
KR102629635B1 (ko) * 2021-05-13 2024-01-30 주식회사 비티진 신규한 비피도박테리움 롱검 균주 및 이의 용도
KR20230000126A (ko) * 2021-06-24 2023-01-02 제주대학교 산학협력단 락토바실러스 속 미생물을 이용한 복합발효물을 유효성분으로 포함하는 간 기능 개선용 조성물
KR102616412B1 (ko) * 2021-07-30 2023-12-21 주식회사 메디오젠 비피도박테리움 애니말리스 락티스 mg741 균주를 포함하는 비만 또는 비알콜성 지방간 예방 또는 치료용 조성물
KR20230076633A (ko) 2021-11-24 2023-05-31 김정현 장내 박테로이데테스를 증가시키는 건강기능식품
WO2023121955A1 (en) * 2021-12-20 2023-06-29 Tainnovation Inc. The methods of and compositions for treating obesity, obesity-related diseases or cancers using a n6-methyllysine/l-lysine mixture
CN114250179B (zh) * 2021-12-22 2023-06-27 苏州普瑞森生物科技有限公司 一种具有减肥功效的微生物组合及其应用
KR102756516B1 (ko) * 2021-12-29 2025-01-21 (주)비타바이오 신규한 유산균 류코노스톡 락티스 VITA7(Leuconostoc lactis VITA7, KCTC18966P) 및 이를 포함하는 항비만 조성물
CN114437968B (zh) * 2022-01-11 2023-06-27 南京农业大学 一株具有缓解肥胖功能的嗜酸乳杆菌nx2-6及应用
CN115466689B (zh) * 2022-02-09 2023-06-16 中国科学技术大学 用于预防和/或治疗代谢类疾病的益生菌组合物及其应用
CN114426941A (zh) * 2022-04-02 2022-05-03 北京量化健康科技有限公司 副干酪乳杆菌Glu-07及其应用
CN115300605A (zh) * 2022-08-16 2022-11-08 比菲德(北京)生物科技有限公司 一种用于抗肥胖、瘦身的益生菌粉及其应用
KR102720937B1 (ko) * 2023-05-22 2024-10-25 한동대학교 산학협력단 프로바이오틱스 균주를 포함하는 비만 예방 및 체력 증진용 사료 조성물
CN118256375B (zh) * 2024-03-05 2024-09-17 四川高福记生物科技有限公司 一株用于调节血压及糖脂代谢的罗伊氏粘液乳杆菌及其应用
CN118285510A (zh) * 2024-06-06 2024-07-05 成都衡美精研健康科技有限公司 加速脂肪代谢的复合益生菌组合物、制备方法及应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6368591B2 (en) * 1998-05-15 2002-04-09 Shanghai Sine Pharmaceutical Corporation Ltd. Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof
JP4580542B2 (ja) * 2000-05-17 2010-11-17 株式會社バイオニア 肥満又は糖尿病治療用微生物及びその微生物を含む医薬組成物
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
ITRM20010763A1 (it) 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.
EP1344458A1 (en) * 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Probiotic delivery system
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
US8871266B2 (en) 2003-10-01 2014-10-28 Commonwealth Scientific & Industrial Research Organisation Probiotic storage and delivery
JP2006191830A (ja) * 2005-01-12 2006-07-27 Unitika Ltd 脂肪の蓄積を抑制する食品
TR201820329T4 (tr) * 2005-02-28 2019-01-21 Nutricia Nv Probiyotik İçeren Besin Bileşimi
JPWO2006103750A1 (ja) * 2005-03-29 2008-09-04 日本ハム株式会社 肥満改善用組成物、機能性食品及び医薬用組成物
JP2006212021A (ja) * 2005-08-05 2006-08-17 Ajinomoto Co Inc 食品組成物
KR101270962B1 (ko) * 2005-09-08 2013-06-11 가부시키가이샤 야쿠르트 혼샤 콜레스테롤 흡수 억제제
EP1981516B1 (en) * 2006-01-27 2018-08-08 DuPont Nutrition Biosciences ApS Use of probiotic microorganisms for the treatment and prevention of obesity and related disorders
CA2689862A1 (en) * 2006-06-09 2007-12-13 Nutravital Inc. Probiotic compositions comprising propionibacterium and uses thereof
US8066986B2 (en) * 2007-02-01 2011-11-29 Master Supplements, Inc. Formulations including digestive enzymes and polysorbate surfactants that enhance the colonization of administered probiotics microoganisms
KR20080075971A (ko) 2007-02-14 2008-08-20 (주)네오팜 프로바이오틱스 복합 제제
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
EP2011506A1 (en) * 2007-07-05 2009-01-07 Nestec S.A. Supplementation of maternal diet
KR100872911B1 (ko) 2007-10-25 2008-12-10 두두원발효(주) 김치유산균으로 발효한 콩 요구르트를 유효성분으로함유하는 비만억제용 조성물
ES2702977T3 (es) * 2009-06-19 2019-03-06 Dupont Nutrition Biosci Aps Bifidobacterias para el tratamiento de diabetes y afecciones relacionadas
FR2955495B1 (fr) * 2010-01-27 2012-05-11 Biocodex Medicament pour la reduction de la cholesterolemie
US9579353B2 (en) * 2011-06-10 2017-02-28 Prothera, Inc. Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
CN103250785B (zh) 2013-04-18 2015-08-26 河南科技大学 一种菊粉低脂酸奶布丁及其制备方法

Also Published As

Publication number Publication date
KR20150118084A (ko) 2015-10-21
ES2770401T3 (es) 2020-07-01
US20140079676A1 (en) 2014-03-20
KR20210013352A (ko) 2021-02-03
CA3092314A1 (en) 2014-03-27
CA3092318A1 (en) 2014-03-27
EP2898061B1 (en) 2019-11-06
EP2898061A1 (en) 2015-07-29
PL2898061T3 (pl) 2020-10-19
CA2885537A1 (en) 2014-03-27
AU2013318513A1 (en) 2015-04-09
AU2019204843A1 (en) 2019-07-25
JP2015530406A (ja) 2015-10-15
US20190083551A1 (en) 2019-03-21
JP6286434B2 (ja) 2018-02-28
CA2885537C (en) 2021-11-23
CN104968780A (zh) 2015-10-07
EP2898061A4 (en) 2016-03-16
EP3593811A1 (en) 2020-01-15
WO2014046804A1 (en) 2014-03-27
PT2898061T (pt) 2020-02-14
AU2021204050A1 (en) 2021-07-08

Similar Documents

Publication Publication Date Title
DK2898061T3 (da) Probiotiske sammensætninger til behandlingen af fedme og fedme-relaterede tilstande
DK2929031T5 (da) Pcsk9-irna-sammensætninger og fremgangsmåder til anvendelse deraf
DK3628161T3 (da) Synergistiske bakterielle sammensætninger og fremgangsmåder til fremstilling og anvendelse deraf
DK3444342T3 (da) Fremgangsmåder og sammensætninger til behandlingen af lysosomale aflejringssygdomme
DK3252160T3 (da) Systemer, fremgangsmåder og sammensætninger med crispr-cas-bestanddele til sekvensmanipulation
DK2872153T3 (da) Accellulære pro-tolerogene sammensætninger og fremgangsmåde til fremstilling heraf
DK3008168T3 (da) Sc-celler og sammensætninger og fremgangsmåde til dannelse deraf
DK2739293T3 (da) Fremgangsmåder og sammensætninger til frembringelse af vaccinavirus
DK2961831T3 (da) Sammensætninger og fremgangsmåder til immunterapi
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK2882496T3 (da) Behandling og diagnosticering af melanom
DK2776567T3 (da) Sammensætninger og fremgangsmåder til behandling af cytomegalovirus.
DK3366307T3 (da) Sammensætninger og fremgangsmåder til inhibering af masp-1 og/eller masp-3 til behandling af paroxystisk nokturn hæmoglobinuri
DK2804587T3 (da) Formulering og fremgangsmåde til øgning af lægemidlers biotilgængelighed
DK3520805T3 (da) Sammensætninger til behandling af myelofibrose
DK2623586T3 (da) Sammensætninger og fremgangsmåder til overfladebehandling med lipaser
DK2970872T3 (da) Mikroorganismer og fremgangsmåder til fremstilling af sialylerede og N-acetylglucosamin-holdige oligosaccharider
BR112015003227A2 (pt) processos de clicoconjugação e composições
DK3685848T3 (da) Sammensætninger og fremgangsmåder til behandling af pulmonal hypertension
DK2818481T3 (da) Farmaceutisk sammensætning til behandling og/eller forebyggelse af cancer
DK3378862T3 (da) Dihydropyrimidinoisoquinolinoner og farmaceutiske sammensætninger deraf til behandlingen af multipel sklerose
DK3366143T3 (da) Probiotiske sammensætninger og fremgangsmåder
DK3238707T3 (da) Sammensætninger og fremgangsmåder til behandling af intestinal hyperpermeabilitet
DK3007695T3 (da) Sammensætninger og fremgangsmåder til behandling af anæmi
DK2688557T3 (da) Fremgangsmåder og sammensætninger til behandling af forstyrelse af opmærksomhed